GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 39 filers reported holding GAMIDA CELL LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $11,273,000 | +26.7% | 1,343,667 | -37.3% | 0.44% | -8.7% |
Q3 2020 | $8,896,000 | -9.2% | 2,143,667 | 0.0% | 0.48% | -19.7% |
Q2 2020 | $9,797,000 | +224.4% | 2,143,667 | +114.4% | 0.60% | +114.9% |
Q1 2020 | $3,020,000 | -29.8% | 1,000,000 | 0.0% | 0.28% | -13.8% |
Q4 2019 | $4,300,000 | -0.7% | 1,000,000 | 0.0% | 0.33% | -28.4% |
Q3 2019 | $4,330,000 | -14.8% | 1,000,000 | 0.0% | 0.46% | -18.0% |
Q2 2019 | $5,080,000 | – | 1,000,000 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
Platform Technology Partners | 45,375 | $291,000 | 0.12% |
PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |